Skip to main content
. Author manuscript; available in PMC: 2013 Jun 4.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Jul 19;19(9):2199–2210. doi: 10.1158/1055-9965.EPI-10-0196

Table 3.

Relationship between age, gender, and objective melanoma risk factors, sun protective behaviour and motivational/attitudinal factors (all scales range from 0 to 4).

Total use of recommended sun protection Perceived vulnerability Perceived severity Worry about developing a melanoma Benefits of protection behaviour Self-efficacy to protect Attitude towards suntans Barriers to sun protection
Gender p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 n.s. n.s.
 Men 1.38 (0.76) 2.03 (0.85) 3.12 (0.62) 2.69 (0.77) 2.86 (0.61) 2.43 (1.10) 2.72 (0.76) 1.79 (0.54)
 Women 1.51 (0.80) 2.12 (0.83) 3.25 (0.60) 2.91 (0.69) 2.99 (0.58) 2.31 (1.10) 2.78 (0.77) 1.80 (0.56)
Age p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 n.s. p<0.001 p<0.001
 <25 1.28 (0.74) 2.00 (0.81) 3.14 (0.61) 2.85 (0.74) 2.88 (0.62) 2.30 (1.13) 2.85 (0.77) 2.02 (0.53)
 25–30 1.46 (0.78) 2.05 (0.79) 3.22 (0.58) 2.88 (0.68) 2.98 (0.57) 2.37 (1.06) 2.78 (0.74) 1.82 (0.55)
 31–40 1.52 (0.78) 2.14 (0.83) 3.22 (0.60) 2.90 (0.70) 2.99 (0.57) 2.36 (1.09) 2.78 (0.73) 1.77 (0.55)
 41–50 1.59 (0.82) 2.18 (0.88) 3.27 (0.61) 2.85 (0.75) 2.99 (0.59) 2.40 (1.12) 2.73 (0.81) 1.69 (0.53)
 >50 1.57 (0.83) 2.13 (0.86) 3.24 (0.62) 2.77 (0.74) 2.93 (0.58) 2.13 (1.11) 2.63 (0.78) 1.65 (0.53)
p<0.001 p<0.001 p<0.001 n.s. n.s. n.s. p<0.001 n.s.
Hair colour
 Black/Brown 1.45 (0.79) 2.04 (0.82) 3.20 (0.61) 2.84 (0.72) 2.95 (0.59) 2.34 (1.11) 2.51 (0.66) 1.80 (0.55)
 Blond/Red 1.57 (0.80) 2.27 (0.86) 3.26 (0.61) 2.89 (0.74) 2.98 (0.59) 2.35 (1.08) 2.44 (0.68) 1.79 (0.56)
Fitzpatrick skin type p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 n.s. p<0.001 p<0.001
 III/IV 1.32 (0.74) 1.95 (0.78) 3.18 (0.61) 2.79 (0.72) 2.91 (0.60) 2.34 (1.10) 2.59 (0.62) 1.85 (0.54)
 I/II 1.80 (0.81) 2.39 (0.87) 3.28 (0.59) 2.98 (0.71) 3.05 (0.55) 2.35 (1.10) 2.28 (0.71) 1.70 (0.57)
Presence of freckles p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 n.s. p<0.001 p<0.001
 None 1.32 (0.76) 1.91 (0.79) 3.17 (0.61) 2.73 (0.74) 2.88 (0.61) 2.37 (1.11) 2.56 (0.64) 1.83 (0.55)
 A few/Many 1.60 (0.79) 2.25 (0.84) 3.25 (0.60) 2.95 (0.69) 3.01 (0.56) 2.33 (1.09) 2.43 (0.68) 1.77 (0.55)
Sunburn before age 16 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 n.s.
 Never 1.32 (0.77) 1.78 (0.79) 3.13 (0.62) 2.68 (0.74) 2.85 (0.61) 2.24 (1.14) 2.57 (0.63) 1.81 (0.55)
 1–3 times 1.51 (0.78) 2.08 (0.80) 3.22 (0.60) 2.87 (0.70) 2.97 (0.57) 2.42 (1.07) 2.46 (0.65) 1.78 (0.56)
Almost every summer 1.62 (0.83) 2.49 (0.83) 3.31 (0.59) 3.01 (0.73) 3.04 (0.59) 2.31 (1.12) 2.44 (0.73) 1.80 (0.58)
Number of large mole (>6mm) p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 n.s.
 None 1.32 (0.77) 1.78 (0.79) 3.13 (0.62) 2.68 (0.74) 2.85 (0.61) 2.24 (1.14) 2.57 (0.63) 1.81 (0.55)
 1–2 1.44 (0.77) 1.93 (0.75) 3.17 (0.61) 2.81 (0.68) 2.90 (0.57) 2.37 (1.10) 2.48 (0.64) 1.78 (0.56)
 >=3 1.57 (0.80) 2.27 (0.83) 3.27 (0.60) 2.94 (0.72) 3.20 (0.58) 2.39 (1.09) 2.45 (0.69) 1.79 (0.56)
Family history of melanoma p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 n.s. p<0.001 p<0.001
 No 1.45 (0.78) 2.04 (0.81) 3.20 (0.61) 2.82 (0.72) 2.94 (0.59) 2.35 (1.10) 2.50 (0.66) 1.81 (0.55)
 Yes 1.80 (0.82) 2.82 (0.78) 3.44 (0.57) 3.21 (0.69) 3.10 (0.55) 2.25 (1.07) 2.33 (0.69) 1.68 (0.58)
Previous melanoma p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 p<0.001
 No 1.43 (0.77) 2.00 (0.77) 3.20 (0.61) 2.81 (0.71) 2.95 (0.59) 2.36 (1.09) 2.51 (0.65) 1.81 (0.55)
 Yes 2.09 (0.84) 3.41 (0.57) 3.49 (0.56) 3.48 (0.65) 3.06 (0.57) 2.14 (1.27) 2.28 (0.78) 1.56 (0.55)
Total number of risk factors p<0.001 p<0.001 p<0.001 p<0.001 p<0.001 n.s. p<0.001 p<0.001
 0–3 1.27 (0.74) 1.76 (0.73) 3.14 (0.62) 2.71 (0.74) 2.86 (0.62) 2.32 (1.12) 2.62 (0.62) 1.85 (0.55)
 4–5 1.48 (0.77) 2.08 (0.77) 3.22 (0.60) 2.85 (0.69) 2.98 (0.57) 2.39 (1.09) 2.47 (0.66) 1.81 (0.54)
 >5 1.84 (0.81) 2.64 (0.83) 3.33 (0.58) 3.09 (0.70) 3.06 (0.55) 2.33 (1.10) 2.30 (0.71) 1.70 (0.58)
HHS Vulnerability Disclosure